Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Burak Ersak

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
World Journal of Surgical Oncology|December 20, 2024
Surgery for patients with endometrioid-type endometrial cancer: is lymphadenectomy above the inferior mesenteric artery necessary?Abdurrahman Alp Tokalioglu, Okan Oktar, Mehmet Unsal, et al.
Turkish Journal of Medical Sciences|May 9, 2025
Survival of patients with 2014 FIGO stage IIIC high-grade serous ovarian cancer who were treated with platin-based adjuvant chemotherapyMehmet Ünsal, Meltem Yücesoy, Okan Oktar, et al.
Journal of Obstetrics and Gynaecology : the Journal of the Institute of Obstetrics and Gynaecology|December 12, 2022
Neoadjuvant chemotherapy in patients with stage IVB uterine serous carcinoma: a Turkish multicentric studyMehmet Unsal, Cigdem Kilic, Caner Cakir, et al.
Cytopathology : Official Journal of the British Society for Clinical Cytology|July 11, 2024
Does HPV-18 co-infection increase the risk of cervical pathology in individuals with HPV-16?Mustafa Gökkaya, Aysun Alcı, Okan Aytekin, et al.
Diagnostics (Basel, Switzerland)|November 13, 2025
Survival Outcomes and Prognostic Factors for Patients in Early Stage Cervical Cancer: A Multicentric Study in TurkeyYesim Ozkaya Ucar, Okan Aytekin, Necim Yalcin, et al.
Oncology Letters|May 8, 2025
Intermediate‑risk factors affecting oncological outcome in patients with FIGO 2018 stage IB2 cervical cancer who do not receive adjuvant therapyAbdurrahman Alp Tokalioglu, Okan Oktar, Okan Aytekin, et al.
Cytopathology : Official Journal of the British Society for Clinical Cytology|December 26, 2022
Clinicopathological features of atypical glandular cells, not otherwise specified, on cervicovaginal pap smearsOkan Aytekin, Caner Cakir, Mehmet Unsal, et al.
Journal of Adolescent and Young Adult Oncology|December 9, 2020
Retrospective Analysis of Pure Ovarian Immature Teratoma in Patients Aged 15-39 Years: A Turkish Multicenter StudyDilek Yüksel, Sevgi Ayhan, Vakkas Korkmaz, et al.
Journal of Obstetrics and Gynaecology : the Journal of the Institute of Obstetrics and Gynaecology|August 24, 2022
Post-recurrence survival analysis of patients with pulmonary recurrence from gynaecologic cancers: a multi-institutional analysis of 122 patientsBurak Ersak, Serra Akar, Gökhan Demirayak, et al.
Journal of the Turkish German Gynecological Association|June 13, 2024
Do HPV 16 positive/ASC-H cervical cancer screening results predict CIN 2+ better than other high-risk HPV subtypes?Abdurrahman Alp Tokalıoğlu, Aysun Alcı, Okan Oktar, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
World Journal of Surgical Oncology|December 20, 2024
Surgery for patients with endometrioid-type endometrial cancer: is lymphadenectomy above the inferior mesenteric artery necessary?Abdurrahman Alp Tokalioglu, Okan Oktar, Mehmet Unsal, et al.
Turkish Journal of Medical Sciences|May 9, 2025
Survival of patients with 2014 FIGO stage IIIC high-grade serous ovarian cancer who were treated with platin-based adjuvant chemotherapyMehmet Ünsal, Meltem Yücesoy, Okan Oktar, et al.
Journal of Obstetrics and Gynaecology : the Journal of the Institute of Obstetrics and Gynaecology|December 12, 2022
Neoadjuvant chemotherapy in patients with stage IVB uterine serous carcinoma: a Turkish multicentric studyMehmet Unsal, Cigdem Kilic, Caner Cakir, et al.
Cytopathology : Official Journal of the British Society for Clinical Cytology|July 11, 2024
Does HPV-18 co-infection increase the risk of cervical pathology in individuals with HPV-16?Mustafa Gökkaya, Aysun Alcı, Okan Aytekin, et al.
Diagnostics (Basel, Switzerland)|November 13, 2025
Survival Outcomes and Prognostic Factors for Patients in Early Stage Cervical Cancer: A Multicentric Study in TurkeyYesim Ozkaya Ucar, Okan Aytekin, Necim Yalcin, et al.
Oncology Letters|May 8, 2025
Intermediate‑risk factors affecting oncological outcome in patients with FIGO 2018 stage IB2 cervical cancer who do not receive adjuvant therapyAbdurrahman Alp Tokalioglu, Okan Oktar, Okan Aytekin, et al.
Cytopathology : Official Journal of the British Society for Clinical Cytology|December 26, 2022
Clinicopathological features of atypical glandular cells, not otherwise specified, on cervicovaginal pap smearsOkan Aytekin, Caner Cakir, Mehmet Unsal, et al.
Journal of Adolescent and Young Adult Oncology|December 9, 2020
Retrospective Analysis of Pure Ovarian Immature Teratoma in Patients Aged 15-39 Years: A Turkish Multicenter StudyDilek Yüksel, Sevgi Ayhan, Vakkas Korkmaz, et al.
Journal of Obstetrics and Gynaecology : the Journal of the Institute of Obstetrics and Gynaecology|August 24, 2022
Post-recurrence survival analysis of patients with pulmonary recurrence from gynaecologic cancers: a multi-institutional analysis of 122 patientsBurak Ersak, Serra Akar, Gökhan Demirayak, et al.
Journal of the Turkish German Gynecological Association|June 13, 2024
Do HPV 16 positive/ASC-H cervical cancer screening results predict CIN 2+ better than other high-risk HPV subtypes?Abdurrahman Alp Tokalıoğlu, Aysun Alcı, Okan Oktar, et al.
Pageof 4